Skip to main content

Albers Jeffrey W.'s Form 4 filing

Blueprint Medicines Corp (BPMC) · filed May 29, 2025

Accession no.
0001415889-25-014862
Filed
May 29, 2025
Trade date
May 27, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $505.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Albers Jeffrey W.CIK 0001638474Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 27, 2025Common StockMOption exerciseAcquired+5,000$36.05+$180,250151,630Direct
May 27, 2025Common StockSSaleDisposed−4,350$101.02−$439,437147,280Direct
May 27, 2025Common StockSSaleDisposed−650$101.93−$66,254.5146,630Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 27, 2025Common StockMOption exerciseDisposed−5,000$0.00$092,500Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)